Sommariva, Michele <br/><br/>
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors.  [electronic resource] 

 -  Journal of translational medicine  Jan 2013 
 - 25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/1479-5876-11-25  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antibody-Dependent Cell Cytotoxicity<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cetuximab<br/>Cisplatin--administration & dosage<br/>CpG Islands<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Oligonucleotides--administration & dosage<br/>Ovarian Neoplasms--immunology<br/>Phagocytosis<br/>Xenograft Model Antitumor Assays